Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies

by Stefanie R. Mullins, John P. Vasilakos, Katharina Deschler, Iwen Grigsby, Pete Gillis, Julius John, Matthew J. Elder, John Swales, Elina Timosenko, Zachary Cooper, Simon J. Dovedi, Andrew J. Leishman, Nadia Luheshi, James Elvecrog, Ashenafi Tilahun, Richard Goodwin, Ronald Herbst, Mark A. Tomai, Robert W. Wilkinson
Published 2019-09-01

Binding of soluble yeast β-glucan to human neutrophils and monocytes is complement- dependent

by Nandita eBose, Anissa SH eChan, Faimola eGuerrero, Carolyn M Maristany, Richard M Walsh, Katie E Ertelt, Adria Bykowski Jonas, Keith B Gorden, Christine M Dudney, Lindsay R Wurst, Mike E Danielson, Natalie eElmasry, Andrew S Magee, Myra L Patchen, Xiaohong eQiu, John P Vasilakos
Published 2013-08-01